Effect of prostate massage on the levels of prostate acid phosphatase in the serum and urine
Wadström, J.; Huber, P.R.; Scholer, A.; Rutishauser, G.
Helvetica Chirurgica Acta 51(3-4): 437-440
1984
ISSN/ISBN: 0018-0181 PMID: 6209244 Document Number: 239240
Document emailed within 1 workday
Related Documents
Yamaguchi, K.; Tanaka, M.; Kitagawa, N.; Kotake, T.; Yanagi, S.; Ito, H. 1989: The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers Hinyokika Kiyo. Acta Urologica Japonica 35(6): 987-991Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Bentvelsen, F.M.; Bogdanowicz, J.F.; Oosterom, R.; Schröder, F.H. 1990: A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma Nederlands Tijdschrift Voor Geneeskunde 134(33): 1596-1600
Mannini, D.; Aiello, E.; Maver, P.; Corrado, G.; Vecchi, F.; Bellanova, B. 1987: Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience Minerva Urologica e Nefrologica 39(4): 335-341
Vihko, P.; Kostama, A.; Jänne, O.; Sajanti, E.; Vihko, R. 1980: Rapid radioimmunoassay for prostate-specific acid phosphatase in human serum Clinical Chemistry 26(11): 1544-1547
Amayo, A.; Obara, W. 2004: Serum prostate specific antigen levels in men with benign prostatic hyperplasia and cancer of prostate East African Medical Journal 81(1): 22-26
Sciarra, A.; D'Eramo, G.; Casale, P.; Di Nicola, S.; Di Chiro, C.; De Santis, C.; Loreto, A.; Di Silverio, F. 1999: Penile metastasis from carcinoma of the prostate in a patient with high serum prostate specific antigen levels Minerva Urologica e Nefrologica 51(3): 157-158
Peters, O.; Gorus, F.; De Boeck, M.; Dehou, M.F.; Van Camp, B. 1984: Increased prostate-type acid phosphatase activity in serum and typical bone lesions simulating the presence of prostatic carcinoma Clinical Chemistry 30(5): 803-804
Wu, C.T.; Chuang, C.K.; Chou, C.C.; Chu, S.H.; Chen, H.W.; Chen, C.S.; Chiang, Y.J.; Liao, S.K. 2000: The role of free to total prostate-specific antigen ratio for prostate cancer in screening patients with total serum levels between 4 and 20 ng/ml Chang Gung Medical Journal 23(3): 142-148
Zweig, M.H.; Van Steirteghem, A.C. 1981: Assessment of radioimmunoassay of serum creatine kinase BB (CK-BB) as a tumor marker: studies in patients with various cancers and a comparison of CK-BB concentrations to prostate acid phosphatase concentrations Journal of the National Cancer Institute 66(5): 659-662
Koda, A.; Hiramatsu, M.; Yoshida, Y. 1974: Pharmacological study of prostate extract (III). Critric acid content and aconitase and isocitrate dehydrogenase activities in normal and hypertrophic prostates and the effect of prostate extracts Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(5): 603-608
Xu, Z.-Q.; Hua, L.-X.; Qian, L.-X.; Wu, H.-F. 2002: Effect of transrectal prostatic biopsy on serum prostate specific antigen levels Zhonghua Nan Ke Xue 8(5): 341-342
Ablin, R.J. 1980: Prostate-specific acid phosphatase Clinical Chemistry 26(11): 1632-1633
González Alenda, F.J.; Castro Beiras, J.M.; Martín Curto, L.M.; Avila Blanco, C.; Crespo Díez, A. 1983: Value of prostatic acid phosphatase and its relation to bone gammagraphy in the diagnosis of cancer of the prostate Revista Clinica Espanola 171(1): 47-50
Erdamar, S.; Yang, G.; Harper, J.W.; Lu, X.; Kattan, M.W.; Thompson, T.C.; Wheeler, T.M. 1999: Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 12(8): 751-755
Romas, N.A.; Veenema, R.J.; Hsu, K.C.; Tomashefsky, P.; Lattimer, J.K.; Tannenbaum, M. 1979: Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods Transactions of the American Association of Genito-Urinary Surgeons 71: 26-30
Miyamoto, S.; Jimbo, H.; Totsuka, Y.; Mashimo, T.; Umeyama, T.; Uehara, H.; Shinozaki, T. 1995: Change in serum prostate specific antigen values in men who had no evidence of prostate cancer on initial biopsy Hinyokika Kiyo. Acta Urologica Japonica 41(10): 767-770
Liang, J.; Zhao, X.-Z.; Shi, J.-Y.; Qiu, X.-F.; Zhang, Q.; Zhuang, J.-L.; Wang, W.; Deng, Y.-M.; Huang, H.-F.; Zhang, C.-W.; Guo, H.-Q. 2019: Combination of serum PSA assay, multi-parametric MRi and targeted prostate biopsy for prostate cancer screening in Nanjing Zhonghua Nan Ke Xue 25(9): 815-822
Rahardjo, D.; Kamil, S.T.; Pakasi, L.S. 2000: Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 563-570
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24